Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
Under a Creative Commons license
open access
Keywords
Gastro-enteropancreatic neuroendocrine tumours (GEP-NETs)
177Lu-DOTA-octreotate
[177Lu]Lu-DOTA-TATE
Everolimus
Sunitinib
Quality-Adjusted Life Years (QALYs)
Cited by (0)
© 2021 Published by Elsevier Ltd.